Fas-IN-1(1375105-96-6)
- Name: Fas-IN-1
- Synonyms:FAS-IN-1;1375105-96-6;FASN-IN-4;CHEMBL2147032;4-cyclopropyl-9-(4-quinolin-7-ylphenyl)sulfonyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SCHEMBL4541971;OGGOWHOQMIINAZ-UHFFFAOYSA-N;BCP28627;BDBM50391837;AKOS030526462;CS-3932;4-Cyclopropyl-9-((4-(quinolin-7-yl)phenyl)sulfonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;NCGC00485940-01;HY-12648;FT-0697614;A906146;4-cyclopropyl-9-{[4-(7-quinolinyl)phenyl]sulfonyl}-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
- Molecular Formula:C26H27N3O4S
- Molecular Weight:477.6
- CAS Registry Number:1375105-96-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1375105-96-6 FAS-IN-1
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1375105-96-6 FAS-IN-1
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.1375105-96-6 FAS-IN-1
Assay:98% Appearance:Powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:FAS-IN-1, a diazaspiro derivative, has been found to be a fatty acid synthase inhibitor that probably have potential biological usage in anticancer study.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1209460-19-4/Tert-butyl 2,3-dihydro-2-(hydroxymethyl)benzofuran-7-ylcarbamate
- 1306664-44-7/(1-(5-Bromopyridin-3-ylsulfonyl)pyrrolidin-2-yl)methanol
- 1315545-04-0/5-Bromo-3-methoxy-2-(2-methoxyethoxy)pyridine
- 1048679-01-1/Bis-PCBM
- 1214336-94-3/Methyl 2-bromo-5-fluoropyridine-3-carboxylate
- 1306664-70-9/3-Bromo-5-(4-methoxypiperidin-1-ylsulfonyl)pyridine
- 1315545-05-1/5-Bromo-2-(2-ethoxyethoxy)-3-methoxypyridine
- 1227374-64-2/(11bR)-N-(2,6-Di(anthracen-9-yl)-4-oxido-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide
- 1306711-69-2/3-Bromo-5-(4-ethylpiperidin-1-ylsulfonyl)pyridine
- 1306711-74-9/1-(5-Bromopyridin-3-ylsulfonyl)-n,n-diethylpiperidin-4-amine
- 1227374-65-3/(11bR)-N-(2,6-Di(anthracen-9-yl)-4-oxido-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide
- 1159822-93-1/3-Amino-3-(4-fluorophenyl)propan-1-ol hydrochloride
- 1194374-60-1/Pyrimidine, 2-chloro-5-(1H-pyrazol-1-yl)-
- 1315545-09-5/5-Bromo-3-(2-butoxyethoxy)-2-methoxypyridine
- 1306711-85-2/2-(5-Fluoropyridin-3-ylsulfonyl)octahydropyrrolo[3,4-c]pyrrole
- 1060812-11-4/3-(Aminomethyl)picolinonitrile
- 1194374-68-9/(3-Chloro-5-methoxyphenyl)methanesulfonyl chloride
- 1353955-09-5/tert-Butyl 4-((6-ethoxypyrimidin-4-yl)amino)piperidine-1-carboxylate
- 1375101-06-6/(E)-6-Bromo-3-(6-bromo-1-(2-octyldodecyl)-2-oxoindolin-3-ylidene)-1-(2-octyldodecyl)indolin-2-one
- 1375105-96-6/Fas-IN-1
- 1260860-78-3/Ethyl 2-amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate
- 1306738-89-5/3-Amino[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid
- 1060812-71-6/(5-(Trifluoromethyl)pyrazin-2-YL)methanamine
- 1315613-52-5/(3-Cyclobutylpyridin-2-yl)methanamine
- 1048912-57-7/Dimethyl 2-(3,5-difluorobenzoyl)-2-{2-[4-(methylsulfonyl)phenyl]-2-oxoethyl}malonate
- 1127298-67-2/Olmesartan Medoxomil-d6
- 1147423-11-7/1-((2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)-N-methyl-N-(tetrahydrofuran-3-yl)piperidin-4-amine
- 1083053-33-1/2,3-Butanedione-13C4
- 1048912-73-7/5-Methoxy-4-(piperazin-1-yl)-2-(trifluoromethyl)pyrimidine
- 1353955-46-0/tert-Butyl 4-((6-methoxypyrimidin-4-yl)amino)piperidine-1-carboxylate